Kounis syndrome not induced but prevented by the implantation of a drug-eluting stent: A case report
dc.contributor.author | Alışır, Mehmet Fethi | |
dc.contributor.buuauthor | Terzioğlu, Kadriye | |
dc.contributor.buuauthor | Ediger, Dane | |
dc.contributor.buuauthor | Öztürk, Raziye Tülümen | |
dc.contributor.buuauthor | Durmuş, Eda | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Allerji ve İmmünoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-2954-4293 | tr_TR |
dc.contributor.researcherid | AAE-9142-2019 | tr_TR |
dc.contributor.scopusid | 56404619600 | tr_TR |
dc.contributor.scopusid | 8833423000 | tr_TR |
dc.contributor.scopusid | 57194142869 | tr_TR |
dc.contributor.scopusid | 56506969700 | tr_TR |
dc.date.accessioned | 2023-03-02T08:16:50Z | |
dc.date.available | 2023-03-02T08:16:50Z | |
dc.date.issued | 2017-05 | |
dc.description.abstract | Kounis syndrome is an allergy-associated acute coronary syndrome, which develops secondary to mast cell activation in coronary arteries due to hypersensitivity or anaphylactoid reaction (1). The triggering factors may be various drugs, food, environmental exposure, and intracoronary stents (2–4). In this case report, an extraordinary case of Kounis syndrome (acute myocardial infarction with concomitant allergic reaction to paracetamol/propyphenazone) has been presented. | en_US |
dc.identifier.citation | Terzioğlu, K. vd. (2017). ''Kounis syndrome not induced but prevented by the implantation of a drug-eluting stent: A case report''. Anatolian Journal of Cardiology, 17(5), 412-413. | en_US |
dc.identifier.endpage | 413 | tr_TR |
dc.identifier.issn | 2149-2263 | |
dc.identifier.issn | 2149-2271 | |
dc.identifier.issue | 5 | tr_TR |
dc.identifier.pubmed | 28529288 | tr_TR |
dc.identifier.scopus | 2-s2.0-85018918444 | tr_TR |
dc.identifier.startpage | 412 | tr_TR |
dc.identifier.uri | https://doi.org/10.14744/AnatolJCardiol.2017.7690 | |
dc.identifier.uri | https://anatoljcardiol.com/jvi.aspx?un=AJC-08522 | |
dc.identifier.uri | http://hdl.handle.net/11452/31285 | |
dc.identifier.volume | 17 | tr_TR |
dc.identifier.wos | 000403533300014 | |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Aves | en_US |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Anatolian Journal of Cardiology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cardiovascular system & cardiology | en_US |
dc.subject | Hypersensitivity | en_US |
dc.subject | Anaphylaxis | en_US |
dc.subject | Management | en_US |
dc.subject | Diagnosis | en_US |
dc.subject | Patient | en_US |
dc.subject.emtree | Acetylsalicylic acid | en_US |
dc.subject.emtree | Creatine kinase MB | en_US |
dc.subject.emtree | Cyclooxygenase 1 | en_US |
dc.subject.emtree | Meloxicam | en_US |
dc.subject.emtree | Paracetamol | en_US |
dc.subject.emtree | Propyphenazone | en_US |
dc.subject.emtree | Troponin I | en_US |
dc.subject.emtree | Nonsteroid antiinflammatory agent | en_US |
dc.subject.emtree | Paracetamol | en_US |
dc.subject.emtree | Phenazone | en_US |
dc.subject.emtree | Propyphenazone | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Anaphylaxis | en_US |
dc.subject.emtree | Angioneurotic edema | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Common cold | en_US |
dc.subject.emtree | Coronary angiography | en_US |
dc.subject.emtree | Coronary artery bypass graft | en_US |
dc.subject.emtree | Diabetes mellitus | en_US |
dc.subject.emtree | Drug eluting stent | en_US |
dc.subject.emtree | Drug hypersensitivity | en_US |
dc.subject.emtree | Dyspnea | en_US |
dc.subject.emtree | Electrocardiography | en_US |
dc.subject.emtree | Faintness | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Hand edema | en_US |
dc.subject.emtree | Heart auscultation | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hypertension | en_US |
dc.subject.emtree | Kounis syndrome | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Non ST segment elevation myocardial infarction | en_US |
dc.subject.emtree | Note | en_US |
dc.subject.emtree | Paclitaxel eluting coronary stent | en_US |
dc.subject.emtree | Percutaneous coronary intervention | en_US |
dc.subject.emtree | Physical examination | en_US |
dc.subject.emtree | Pruritus | en_US |
dc.subject.emtree | Pulse rate | en_US |
dc.subject.emtree | Stenosis | en_US |
dc.subject.emtree | Swelling | en_US |
dc.subject.emtree | Thorax pain | en_US |
dc.subject.emtree | Urticaria | en_US |
dc.subject.emtree | Vital sign | en_US |
dc.subject.emtree | Analogs and derivatives | en_US |
dc.subject.emtree | Combination drug therapy | en_US |
dc.subject.emtree | Diagnostic imaging | en_US |
dc.subject.emtree | Differential diagnosis | en_US |
dc.subject.emtree | Kounis syndrome | en_US |
dc.subject.emtree | Non insulin dependent diabetes mellitus | en_US |
dc.subject.mesh | Acetaminophen | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Anti-inflammatory agents, non-steroidal | en_US |
dc.subject.mesh | Antipyrine | en_US |
dc.subject.mesh | Diabetes mellitus, type 2 | en_US |
dc.subject.mesh | Diagnosis, differential | en_US |
dc.subject.mesh | Drug Therapy, Combination | en_US |
dc.subject.mesh | Drug-eluting stents | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypertension | en_US |
dc.subject.mesh | Kounis syndrome | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.scopus | Kounis Syndrome; Hypersensitivity; Anaphylaxis | en_US |
dc.subject.wos | Cardiac & cardiovascular systems | en_US |
dc.title | Kounis syndrome not induced but prevented by the implantation of a drug-eluting stent: A case report | en_US |
dc.type | Editorial Material | |
dc.wos.quartile | Q4 | en_US |